BioTelemetry (BEAT) Misses Q3 EPS by 9c

BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.16, $0.09 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $81 million versus the consensus estimate of $82.62 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Odysight.AI Inc. (ODYS) PT Lowered to $6 at Benchmark
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat